Carregant...
Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
BACKGROUND: The main limitation of current immune checkpoint inhibitors (ICIs) in the treatment of cervical cancer comes from the fact that it benefits only a minority of patients. The study aims to develop a classification system to identify immune subtypes of cervical squamous cell carcinoma (SCC)...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142504/ https://ncbi.nlm.nih.gov/pubmed/34030694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02894-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|